Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Shields

Showing results (381-390 of 413) with videos related to

Pageof 42
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2017
Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial PathogensSamuel A Shelburne, Jiwoong Kim, Jose M Munita, et al.
Mbio|November 2, 2017
<i>Klebsiella pneumoniae</i> Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein EngineeringMelissa D Barnes, Marisa L Winkler, Magdalena A Taracila, et al.
Clinical Pharmacology and Therapeutics|May 18, 2007
An evaluation of computer-aided disproportionality analysis for post-marketing signal detectionH P Lehman, J Chen, A L Gould, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 25, 2025
How do I manage Difficult-to-Treat Pseudomonas aeruginosa infections?: Key Questions for Today's CliniciansJuan P Horcajada, Ana Gales, Burcu Isler, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2020
Achievement of clinical isavuconazole blood concentrations in transplant recipients with isavuconazonium sulphate capsules administered via enteral feeding tubeErin K McCreary, M Hong Nguyen, Matthew R Davis, et al.
Clinical Microbiology Reviews|October 9, 2025
Current and future options for the treatment of serious infections due to carbapenem-resistant <i>Pseudomonas aeruginosa</i>Juan P Horcajada, Ana C Gales, Burcu Isler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2012
Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasisM Hong Nguyen, Mark C Wissel, Ryan K Shields, et al.
Antimicrobial Agents and Chemotherapy|October 23, 2013
Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimensLucio R Minces, M Hong Nguyen, Dimitra Mitsani, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 19, 2012
Staphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomesRyan K Shields, Cornelius J Clancy, Lucio R Minces, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2022
Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-AvibactamT A Alsenani, S L Viviani, V Kumar, et al.
Pageof 42

Showing results (381-390 of 413) with videos related to

Sort By:
Pageof 42
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2017
Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial PathogensSamuel A Shelburne, Jiwoong Kim, Jose M Munita, et al.
Mbio|November 2, 2017
<i>Klebsiella pneumoniae</i> Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein EngineeringMelissa D Barnes, Marisa L Winkler, Magdalena A Taracila, et al.
Clinical Pharmacology and Therapeutics|May 18, 2007
An evaluation of computer-aided disproportionality analysis for post-marketing signal detectionH P Lehman, J Chen, A L Gould, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 25, 2025
How do I manage Difficult-to-Treat Pseudomonas aeruginosa infections?: Key Questions for Today's CliniciansJuan P Horcajada, Ana Gales, Burcu Isler, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2020
Achievement of clinical isavuconazole blood concentrations in transplant recipients with isavuconazonium sulphate capsules administered via enteral feeding tubeErin K McCreary, M Hong Nguyen, Matthew R Davis, et al.
Clinical Microbiology Reviews|October 9, 2025
Current and future options for the treatment of serious infections due to carbapenem-resistant <i>Pseudomonas aeruginosa</i>Juan P Horcajada, Ana C Gales, Burcu Isler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2012
Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasisM Hong Nguyen, Mark C Wissel, Ryan K Shields, et al.
Antimicrobial Agents and Chemotherapy|October 23, 2013
Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimensLucio R Minces, M Hong Nguyen, Dimitra Mitsani, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 19, 2012
Staphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomesRyan K Shields, Cornelius J Clancy, Lucio R Minces, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2022
Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-AvibactamT A Alsenani, S L Viviani, V Kumar, et al.
Pageof 42